Lyr 210 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lyr 210. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lyr 210 Today - Breaking & Trending Today
Less than a week ago, executives at Lyra Therapeutics Inc. were looking ahead to “imminent” data from its first phase III study in chronic rhinosinusitis (CRS), testing drug-device candidate LYR-210, a drug-device candidate largely expected to fill a much-needed gap in CRS treatment. On Monday, May 6, they were announcing plans to preserve cash in the wake of the failed Enlighten 1 study, which raised doubts as to the feasibility of the company’s CRS programs, which also include the similarly designed candidate LYR-220. ....